# Distinguishing Patient Groups Using Autonomic Dysfunction

> **NCT04964921** · — · UNKNOWN · sponsor: **DyAnsys, Inc.** · enrollment: 200 (estimated)

## Conditions studied

- Diabetes

## Interventions

- **OTHER:** Device: ANSiScope Plus

## Key facts

- **NCT ID:** NCT04964921
- **Lead sponsor:** DyAnsys, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12
- **Primary completion:** 2022-02
- **Final completion:** 2022-02
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04964921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04964921, "Distinguishing Patient Groups Using Autonomic Dysfunction". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04964921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*